Predictive factors for hyperprogressive disease during nivolumab as anti-PD1 treatment in patients with advanced gastric cancer

Akinori Sasaki, Yoshiaki Nakamura, Saori Mishima et al. · Gastric Cancer · 2019

Cited by 161 works. doi:10.1007/s10120-018-00922-8 Open-access PDF

Authors

References